Overview
What Surgimate does: Surgimate provides surgical scheduling software for medical practices, hospitals, and surgical centers to streamline the booking of surgeries, maximize operating room block time, and boost surgical revenue. How the product works: The platform automates and coordinates surgery scheduling to improve throughput and reduce scheduling costs, with a subscription-based model that charges clients recurring fees for access and features. How it differs from competitors: It emphasizes surgical orchestration and tangible outcomes, backed by data such as a 22% reduction in scheduling costs and a 30% increase in surgical volume, and operates as a remote-first team across the United States. What the company aims to achieve: To make surgical scheduling more efficient, increase throughput, and grow revenue for healthcare providers.
Work here?Claim your company
Simplify's Take
What believers are saying
- Kraig Brown became CEO on 2025-01-17, bringing 30-plus years of digital health experience.
- Surgimate's July 2025 strategy targets more product innovation after the CEO transition.
- The company says its platform reduces cancellations, coordination time, and scheduling costs.
What critics are saying
- Carepatron, Tebra, and Leap Rail crowd the 2026 alternatives page, pressuring pricing.
- Integration of ImplantBase after February 2025 adds execution risk across two software stacks.
- A platform breach or missed surgery can trigger hospital churn and regulatory scrutiny immediately.
What makes Surgimate unique
- Surgimate owns surgical scheduling, pre-op coordination, and block utilization in one workflow.
- Its 2025 ImplantBase deal extends into medical-device inventory and sales operations.
- Banneker-backed Surgimate managed 750,000 surgical events across 100-plus practices in 2024.
Help us improve and share your feedback! Did you find this helpful?